Over the past few months, IBS Impact has been working on the latest round of updates to our main site. This is always a work in progress as new and useful information comes available, but this is a good time to draw readers’ attention to some of the changes.
There have also been new details and resources added in the latest news column on the left of the home page, IBS page, advocacy page, research page, IBS studies page, resources page, IBS and children page and links page. Of particular interest are the progress of HR 2311, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act, currently under consideration in the U.S. House of Representatives, and updated information for the recently released Rome IV international diagnostic criteria. A couple of new pediatric clinical trial opportunities have been added as well.
Readers interested in the most recent news, events, clinical trial and advocacy opportunities, and articles between main site updates, may follow this blog or our Facebook or Twitter feeds (links found on the lower right sidebar of this blog). Regardless of one’s interest in IBS, whether personal or professional, most users should find useful and interesting material and links. The current site reflects resources in six countries which are among the top sources of hits to the site and this blog.
Because of the redesign and transfer of the site to new hosting in the fall of 2015, some links embedded in older posts on this blog or search engine results relating to IBS Impact.com may result in error messages, but you should still reach the site itself. If so, please use the navigation links at the top of the site to reach the desired subpage. No information that is still currently useful has been removed from the site, although in some cases, the location has changed. Only outdated details and occasional defunct links for which there is no replacement available at this time have been deleted.
Please feel free to check out the site here. Our goals with the website, blog and social media are to provide a varied range of current, scientifically accurate, reputable information and resources to people with IBS and their families and friends, and to encourage informed choices, proactive self-advocacy and public awareness of IBS, and the unmet medical or social needs many of us face as a result of IBS.
IBS Impact as an entity, is not directly affiliated with any other organization, site or research sponsor and receives no funding for the information we post on the main website, this blog or our Twitter and Facebook pages. We do welcome constructive collaboration and value the many individuals, websites, organizations and clinical and research entities who continue to support, encourage and amplify our efforts in various ways to benefit the cause of IBS awareness and advocacy worldwide.
Comments, suggestions, corrections of outdated links, article submissions, and clinical trials or surveys by researchers affiliated with academic, medical, or pharmaceutical entities or reputable organizations representing IBS or commonly overlapping conditions in any country are all welcome and will be thoughtfully considered. A contact form can be found on the home page of the main site, or comments can be left on this blog. Thank you to all of our readers and social media followers for your interest and participation.